Book 16 Meetings With Life Science Investors One Day At RESI

This one-day conference provides the highest ROI in the industry by bringing together innovative technology and active early stage investors looking to deploy capital.
United States Food, Drugs, Healthcare, Life Sciences
To print this article, all you need is to be registered or login on Mondaq.com.

Life Science Nation, Texas Medical Center and Johnson & Johnson Innovation, JLABS, invite fundraising life science companies to attend the upcoming Redefining Early Stage Investments (RESI) Conference in Houston on June 8th. The RESI Conference brings together the most diverse group of early stage investors under one roof, including Family Offices, Venture Philanthropy Funds, VCs, Angel Groups, Corporate Venture Capital Funds, and more.

The RESI Partnering Forum allows fundraising executives to identify and book up to 16 meetings with life science investors who fit their company's technology sector and stage of development. Additionally, through an expansive series of panels and workshops, attendees will have the chance to hear firsthand accounts from investors explaining their current investment mandates and process for identifying and qualifying candidates. This one-day conference provides the highest ROI in the industry by bringing together innovative technology and active early stage investors looking to deploy capital. Take a look here to see our growing list of confirmed investors.

We hope to see you on June 8, 2015 in Houston!

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

Book 16 Meetings With Life Science Investors One Day At RESI

United States Food, Drugs, Healthcare, Life Sciences

Contributor

See More Popular Content From

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More